John Lettieri
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 25
- Antibiotics Pharmacokinetics and Efficacy 23
- Pharmacogenetics and Drug Metabolism 9
- Surgery 17
- Lipoproteins and Cardiovascular Health 10
- Co-authors
- Allen H. Heller (16 shared papers)G.J. Krol (13 shared papers)R. Wayne Frost (6 shared papers)H L Fung (2 shared papers)Roger Echols (3 shared papers)Martin Radtke (2 shared papers)Lee Kaiser (6 shared papers)P. R. Sundaresan (5 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)The Journal of Clinical Pharmacology (7 papers)Atherosclerosis (5 papers)Journal of Cardiovascular Pharmacology (4 papers)Plastic & Reconstructive Surgery (4 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
John Lettieri
76 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 120
- Molecular Medicine 270
- Pharmacology 790
- Toxicology 140
- Applied Microbiology and Biotechnology 63
- Pharmacology 200
Countries citing papers authored by John Lettieri
This map shows the geographic impact of John Lettieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lettieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lettieri more than expected).
Fields of papers citing papers by John Lettieri
This network shows the impact of papers produced by John Lettieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lettieri. The network helps show where John Lettieri may publish in the future.
Co-authors
The 25 scholars most cited alongside John Lettieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 181 | |
| 2 | 1989 | 143 | |
| 3 | 1992 | 124 | |
| 4 | 1999 | 107 | |
| 5 | 1979 | 89 | |
| 6 | 1992 | 82 | |
| 7 | 2013 | 78 | |
| 8 | 1988 | 77 | |
| 9 | Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. | 1978 | 63 |
| 10 | 1989 | 49 | |
| 11 | 1998 | 48 | |
| 12 | 1996 | 41 | |
| 13 | 1999 | 41 | |
| 14 | 1978 | 41 | |
| 15 | 1995 | 41 | |
| 16 | 1989 | 38 | |
| 17 | 1997 | 36 | |
| 18 | 2001 | 34 | |
| 19 | 2017 | 34 | |
| 20 | 1996 | 34 |
About John Lettieri
John Lettieri is a scholar working on Pharmacology, Surgery, Oncology, Pharmacology and Molecular Biology, having authored 77 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Lipoproteins and Cardiovascular Health (10 papers), Pharmacogenetics and Drug Metabolism (9 papers), Epilepsy research and treatment (9 papers), Analytical Methods in Pharmaceuticals (8 papers), Antibiotic Resistance in Bacteria (8 papers), Cancer Treatment and Pharmacology (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Molecular Medicine (270 citations), Pharmacology (790 citations), Toxicology (140 citations), Applied Microbiology and Biotechnology (63 citations) and Pharmacology (200 citations). John Lettieri has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Allen H. Heller, G.J. Krol, R. Wayne Frost, H L Fung, Roger Echols, Martin Radtke, Lee Kaiser, P. R. Sundaresan, Chetan Lathia and Frank Cihon. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Clinical Pharmacology, Atherosclerosis, Journal of Cardiovascular Pharmacology and Plastic & Reconstructive Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.